Načítá se...

Safety, tolerance, and pharmacokinetics of atevirdine mesylate (U-87201E) in asymptomatic human immunodeficiency virus-infected patients.

Atevirdine mesylate (U-87201E) is a new nonnucleoside (bisheteroarylpiperazine) inhibitor of human immunodeficiency virus type 1 reverse transcriptase. In a double-blind, escalating single-dose study the safety, tolerance, and pharmacokinetics of atevirdine mesylate were investigated in 24 asymptoma...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Been-Tiktak, A M, Vrehen, H M, Schneider, M M, van der Feltz, M, Branger, T, Ward, P, Cox, S R, Harry, J D, Borleffs, J C
Médium: Artigo
Jazyk:Inglês
Vydáno: 1995
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC162591/
https://ncbi.nlm.nih.gov/pubmed/7793859
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!